Drug Type Cell therapy |
Synonyms NK 510, NK-510 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Systemic Lupus Erythematosus | Preclinical | CN | 14 Jun 2024 | |
Acute Myeloid Leukemia | Preclinical | CN | 17 Apr 2023 | |
Liver Cancer | Preclinical | CN | 17 Apr 2023 | |
Non-Small Cell Lung Cancer | Preclinical | CN | 17 Apr 2023 | |
Sarcoma | Preclinical | CN | 17 Apr 2023 |